佛慈制药
(002644)
| 流通市值：43.41亿 | | | 总市值：43.41亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 634,614,408.79 | 565,242,741.32 | 524,492,565.97 | 448,669,550.41 |
| 应收票据及应收账款 | 379,020,077.2 | 384,100,347 | 383,610,607.07 | 395,826,835.54 |
| 其中：应收票据 | 40,454,146.37 | 60,503,666.27 | 81,676,070.22 | 60,887,119.01 |
| 应收账款 | 338,565,930.83 | 323,596,680.73 | 301,934,536.85 | 334,939,716.53 |
| 应收款项融资 | 37,862,548.72 | 75,520,290.88 | 90,470,290.93 | 75,579,255.51 |
| 预付款项 | 18,059,290.85 | 7,336,923.69 | 7,805,349.28 | 13,849,133.29 |
| 其他应收款合计 | 11,716,731.87 | 3,899,833.26 | 3,281,823.48 | 21,414,633.18 |
| 存货 | 308,422,626.07 | 293,807,934.6 | 289,840,463.5 | 335,845,283.56 |
| 其他流动资产 | 32,368,120.83 | 33,254,388.68 | 33,240,036.88 | 31,643,749.32 |
| 流动资产合计 | 1,422,063,804.33 | 1,363,162,459.43 | 1,332,741,137.11 | 1,322,828,440.81 |
| 非流动资产: | | | | |
| 长期股权投资 | 46,769,606.25 | 47,914,020.88 | 49,934,022.03 | 50,048,818.67 |
| 其他权益工具投资 | 20,000,000 | 20,000,000 | 20,000,000 | - |
| 投资性房地产 | 5,619,806.63 | 6,390,443.2 | 6,494,922.95 | 6,992,458.95 |
| 固定资产 | 973,834,668.94 | 972,827,532.59 | 984,392,869.44 | 987,758,000.4 |
| 在建工程 | - | - | - | 1,764,636.34 |
| 使用权资产 | 2,549,370.56 | 3,282,317.4 | 2,572,114.75 | 1,346,560.42 |
| 无形资产 | 71,906,752.52 | 72,727,872.48 | 73,552,867.49 | 74,388,906.24 |
| 商誉 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 | 9,009,586.84 |
| 长期待摊费用 | 1,947,076.92 | 1,784,199.87 | 1,842,096.14 | 2,358,607.93 |
| 递延所得税资产 | 65,695,636.65 | 65,681,475.53 | 65,792,793.16 | 65,761,494.9 |
| 其他非流动资产 | 757,795.34 | 676,273.19 | 1,164,067.12 | 1,700,397.29 |
| 非流动资产合计 | 1,198,090,300.65 | 1,200,293,721.98 | 1,214,755,339.92 | 1,201,129,467.98 |
| 资产总计 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 |
| 流动负债: | | | | |
| 短期借款 | 19,755,754.44 | 17,800,000 | 21,695,344.44 | 10,000,000 |
| 应付票据及应付账款 | 334,992,091.62 | 294,127,627.74 | 263,627,358.43 | 267,619,802.02 |
| 其中：应付票据 | 46,058,433 | 46,352,087 | 36,152,494.37 | 13,339,105.37 |
| 应付账款 | 288,933,658.62 | 247,775,540.74 | 227,474,864.06 | 254,280,696.65 |
| 合同负债 | 50,003,541.06 | 50,664,548.69 | 50,754,840.76 | 37,283,586.53 |
| 应付职工薪酬 | 1,778,699.99 | 1,335,762.16 | 1,781,872.22 | 1,109,425.12 |
| 应交税费 | 14,656,883.74 | 20,345,723.64 | 26,265,770.81 | 10,194,886.41 |
| 其他应付款合计 | 57,520,243.35 | 44,324,733.04 | 36,524,878.99 | 50,455,880.96 |
| 一年内到期的非流动负债 | 1,815,697.8 | 2,392,013.95 | 16,088,002.55 | 14,330,249.88 |
| 其他流动负债 | 13,014,573.05 | 16,852,336.63 | 23,883,390.98 | 35,180,210.07 |
| 流动负债合计 | 493,537,485.05 | 447,842,745.85 | 440,621,459.18 | 426,174,040.99 |
| 非流动负债: | | | | |
| 长期借款 | 7,200,000 | 6,200,000 | 6,200,000 | 5,800,000 |
| 租赁负债 | 3,027,536.72 | 2,286,704.33 | 1,510,061.48 | 1,844,240.38 |
| 递延收益 | 231,195,040.05 | 236,288,913.47 | 241,401,060.32 | 241,723,065.17 |
| 递延所得税负债 | 2,178,500.6 | 2,254,701.41 | 2,299,631.24 | 2,471,426.34 |
| 非流动负债合计 | 243,601,077.37 | 247,030,319.21 | 251,410,753.04 | 251,838,731.89 |
| 负债合计 | 737,138,562.42 | 694,873,065.06 | 692,032,212.22 | 678,012,772.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 510,657,000 | 510,657,000 | 510,657,000 | 510,657,000 |
| 资本公积 | 337,393,806.93 | 327,393,806.93 | 337,393,806.93 | 337,393,806.93 |
| 其他综合收益 | -117,719.97 | -36,799 | -36,799 | 32,159 |
| 专项储备 | 666,099.49 | 694,022.13 | 700,479.68 | 952,250.19 |
| 盈余公积 | 136,831,463.42 | 132,732,219.9 | 132,732,219.9 | 126,006,345.3 |
| 未分配利润 | 876,648,686.24 | 873,883,857.54 | 851,222,610.13 | 846,823,689.7 |
| 归属于母公司股东权益合计 | 1,862,079,336.11 | 1,845,324,107.5 | 1,832,669,317.64 | 1,821,865,251.12 |
| 少数股东权益 | 20,936,206.45 | 23,259,008.85 | 22,794,947.17 | 24,079,884.79 |
| 股东权益合计 | 1,883,015,542.56 | 1,868,583,116.35 | 1,855,464,264.81 | 1,845,945,135.91 |
| 负债和股东权益合计 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 | 2,523,957,908.79 |
| 公告日期 | 2026-08-20 | 2026-04-30 | 2026-04-09 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |